DK1613204T3 - Vurdering af neuronal beskadigelse ud fra blodpröver - Google Patents

Vurdering af neuronal beskadigelse ud fra blodpröver

Info

Publication number
DK1613204T3
DK1613204T3 DK04758954T DK04758954T DK1613204T3 DK 1613204 T3 DK1613204 T3 DK 1613204T3 DK 04758954 T DK04758954 T DK 04758954T DK 04758954 T DK04758954 T DK 04758954T DK 1613204 T3 DK1613204 T3 DK 1613204T3
Authority
DK
Denmark
Prior art keywords
assessment
neuronal damage
blood tests
detected
breakdown products
Prior art date
Application number
DK04758954T
Other languages
Danish (da)
English (en)
Inventor
Gerry Shaw
Brian R Pike
Sonal S Tuli
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of DK1613204T3 publication Critical patent/DK1613204T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DK04758954T 2003-03-31 2004-03-26 Vurdering af neuronal beskadigelse ud fra blodpröver DK1613204T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45928603P 2003-03-31 2003-03-31
PCT/US2004/009114 WO2004091379A2 (en) 2003-03-31 2004-03-26 Assessing neuronal damage from blood samples

Publications (1)

Publication Number Publication Date
DK1613204T3 true DK1613204T3 (da) 2009-12-07

Family

ID=33299668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04758954T DK1613204T3 (da) 2003-03-31 2004-03-26 Vurdering af neuronal beskadigelse ud fra blodpröver

Country Status (10)

Country Link
US (3) US20040241762A1 (https=)
EP (1) EP1613204B1 (https=)
JP (1) JP4557971B2 (https=)
AT (1) ATE440286T1 (https=)
AU (1) AU2004229317B2 (https=)
CA (1) CA2520945C (https=)
DE (1) DE602004022645D1 (https=)
DK (1) DK1613204T3 (https=)
ES (1) ES2332136T3 (https=)
WO (1) WO2004091379A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2578680C (en) * 2004-04-15 2011-06-14 University Of Florida Research Foundation, Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
US20070276275A1 (en) * 2006-05-24 2007-11-29 University Of Miami Screening method and system to estimate the severity of injury in critically ill patients
WO2008078809A1 (ja) * 2006-12-27 2008-07-03 Japan Science And Technology Agency 鳥類抗体を使用する免疫学的検出方法
WO2012005588A2 (en) * 2010-07-07 2012-01-12 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Novel biomarkers for detecting neuronal loss
US20170023591A1 (en) * 2014-04-07 2017-01-26 Iron Horse Diagnostics, Inc. Traumatic Brain Injury and Neurodegenerative Biomarkers, Methods, and Systems
WO2020023899A1 (en) * 2018-07-27 2020-01-30 Veravas, Inc. Methods for depletion and enrichment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86652A1 (de) * 1986-11-10 1988-06-13 Progen Biotechnik Gmbh Verfahren zum auffinden von gewebslaesionen
WO1990006993A1 (en) * 1988-12-21 1990-06-28 The General Hospital Corporation Method of detecting neurological disease or dysfunction
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
GB9719879D0 (en) * 1997-09-19 1997-11-19 Neuropa Ltd Protein
US6589746B1 (en) * 1999-10-21 2003-07-08 University Of Cincinnati Method of detecting axonally-derived protein tau in patients with traumatic CNS injury

Also Published As

Publication number Publication date
EP1613204B1 (en) 2009-08-19
CA2520945C (en) 2014-03-25
WO2004091379A3 (en) 2005-12-22
AU2004229317A1 (en) 2004-10-28
JP4557971B2 (ja) 2010-10-06
CA2520945A1 (en) 2004-10-28
ATE440286T1 (de) 2009-09-15
DE602004022645D1 (de) 2009-10-01
US20160349272A1 (en) 2016-12-01
EP1613204A2 (en) 2006-01-11
US20040241762A1 (en) 2004-12-02
JP2006522336A (ja) 2006-09-28
HK1085538A1 (en) 2006-08-25
EP1613204A4 (en) 2007-04-04
ES2332136T3 (es) 2010-01-27
WO2004091379A2 (en) 2004-10-28
US20100184105A1 (en) 2010-07-22
AU2004229317B2 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
ATE493290T1 (de) Alcotestgerät
EP3789764A4 (en) BLOOD TEST METHOD AND BLOOD ANALYSIS SYSTEM
EP4017360A4 (en) HIGHLY INTEGRATED ANALYTE DETECTION DEVICE
CY1117095T1 (el) Συσκευη και μεθοδος για ηλεκτροχημικη ανιχνευση
BRPI0808001A2 (pt) Dispositivo para monitoração de analisado revestido com polímero que contém nitrogênio heterocíclico e métodos de uso.
EP3899022A4 (en) PORTABLE IMPEDANCE-BASED DIAGNOSTIC TEST SYSTEM FOR DETECTING ANALYTES
EP3584575A4 (en) INTEGRATED DEVICE FOR FECAL SAMPLING AND OCCULT BLOOD DETECTION
ATE531820T1 (de) Gesundheitszustandstest
ES2422735T3 (es) Procedimiento para la predicción de un riesgo de reacciones adversas a medicamentos mediante la determinación de HLA-B 1502
EP3798616A4 (en) Chemical luminescence analysis and measurement method, system using same, and kit
EP4012408A4 (en) SAMPLE COLLECTION AND DETECTION DEVICE AND METHOD
EP4408278A4 (en) ANALYTE DETECTION SYSTEM
WO2009099905A3 (en) Molecular signatures and biomarkers associated with melanoma and methods of use thereof
EP4458991A4 (en) PRIMARY PROBE FOR DETECTION, PRIMARY PROBE SET AND CORRESPONDING APPLICATION
EP4524553A3 (en) Definitive development diagnostic analysis
EP3916375A4 (en) DEVICE FOR DETECTING BIOLOGICAL SAMPLES
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
EP4063830A4 (en) ANALYZER AND DETECTION SYSTEM
EP4027682A4 (en) IDC DETECTION METHOD AND APPARATUS AND IDC DETECTION INDICATION METHOD AND APPARATUS
EP3938780A4 (en) BLOOD TEST DEVICE FOR HEMOLYSIS DETECTION
DK1613204T3 (da) Vurdering af neuronal beskadigelse ud fra blodpröver
EP4178453A4 (en) Sample collection device, sample collection kit, sample collection system, diagnostic device, and associated methods
BR0317472A (pt) Sensor colorimétrico e método para detectar um analito, kit descartável para detectar a presença de um analito, método para detectar a presença de bactérias, e, artigo médico
ATE459289T1 (de) Katheter zur abnahme von blut
CY1121482T1 (el) Ευαισθητη πολυπλεκτικη ανοσοδοκιμασια για τους διαλυτους υποδοχεις των αυξητικων παραγοντων των ινοβλαστων